Call: +91-9177734525 | Email: info@opensciencepublications.com

Journal of Plant Science and Research

Research Article

In Vitro Evaluation of Antioxidant and Hypoglycemic Potential of Extracts from Different Parts of Xanthium Strumarium L

Chitra Jain*, Vijaivergiya R and Khatana S

Department of Botany, University of Rajasthan, India
*Corresponding author: Chitra Jain, Department of Botany, University of Rajasthan, Jaipur- 302004, Rajasthan, India; Email: drchitrajainbiochemistry@gmail.com
Copyright: © Jain C, et al. 2021. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Information: Submission: 06/04/2021; Accepted: 05/05/2021; Published: 08/05/2021

Abstract

Introduction: Indian medicinal plants used in the Ayurveda traditional system to treat diabetes and to scavenge free radicals are a valuable source of novel anti-diabetic agents. Alpha amylase inhibitors offer an effective strategy to lower the level of postprandial hyperglycemia via control of starch breakdown. Plant extracts also possesses free radical scavengers which can be used to treat various diseases like cancer. Extracts of Xanthium Strumarium L. have been considered as hypoglycemic and antioxidant agents.
Materials and Methods: In this study, we evaluated antioxidant potential and hypoglycemic potential of methanolic extracts of root, stem, leaves and fruits of the plant by DPPH method and DNSA assay respectively.
Results: Results showed that all plant parts showed very good antioxidant and hypoglycemic activities with low IC50 values.
Discussion: results of present study showed that maximum salivary alpha amylase inhibitory activity was shown by methanolic extract of root with minimum IC50 value i.e.46.70 μg/ml and maximum free radical scavenging activity was shown by methanolic extract of fruits with minimum IC50 value i.e. 0.016 μg/ml. Root extract also show good antioxidant potential.
Conclusion: The results of this study direct researchers to evaluate the therapeutic potential of secondary metabolites in the management of post prandial hyperglycemia and type II diabetes mellitus either alone or in combinatorial therapy.